Protara Therapeutics Ratios (2014-2015) | TARA

Ratios Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015
Profitability
EBT Margin 333.45%8,737.93%5.31%18,500.00%
EBIT Margin 233.45%8,648.28%4.62%25,176.92%
EBITDA Margin 233.45%8,917.24%-178.24%-107,184.62%
Operating Margin 233.45%8,648.28%4.62%25,176.92%
Net Margin 524.52%15,379.31%-257.17%-45,676.92%
FCF Margin 188.65%9,213.79%-128.10%15,815.38%
Efficiency
Assets Average 54.49M82.86M78.75M74.43M
Equity Average -17.05M80.38M76.03M71.40M
Invested Capital -116.55M82.46M78.29M73.76M69.03M
Asset Utilization Ratio 0.040.030.040.00
Leverage & Solvency
Interest Coverage Ratio -2.33-86.48-13.40-251.77
Equity Ratio -4.820.970.970.960.96
Times Interest Earned -2.33-86.48-13.40-251.77
Valuation
Enterprise Value -3.59M-8.65M-21.69M-83.59M-79.53M-74.74M-70.55M
Return Ratios
Return on Sales 3.33%87.38%0.05%185.00%-1.67%-0.78%185.00%
Return on Capital Employed -0.15%
Return on Assets -0.14%-0.06%-0.03%-0.03%
Return on Equity 0.44%-0.06%-0.03%-0.03%